New treatment option offers hope for children with nephropathic cystinosis

Lead ATAC candidate HDP-101 shows strong clinical activity and safety in phase 8 cohort

Real-time process mapping cuts manual workload and boosts frontline efficiency

CGT Catapult annual review shows sector’s impact on economy and patient access

Early treatment with vamorolone shows sustained efficacy and improved safety profile

Deal strengthens CNS portfolio and ensures continuity of access for MS patients

Three-year trial results reveal long-term improvements in pain and lesion resolution

New self-loading reagents offer unmatched flexibility for immunologists

First-in-class mast cell selective c-Kit inhibitor enters clinical testing in Germany

SBT-77-7101 shows favourable safety and early signs of efficacy in patients with refractory RA